...
首页> 外文期刊>Genome Biology >Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in middle eastern families
【24h】

Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in middle eastern families

机译:靶向基因组捕获和大规模平行测序,以鉴定中东家庭遗传性听力损失的基因

获取原文
           

摘要

Background: Identification of genes responsible for medically important traits is a major challenge in human genetics. Due to the genetic heterogeneity of hearing loss, targeted DNA capture and massively parallel sequencing are ideal tools to address this challenge. Our subjects for genome analysis are Israeli Jewish and Palestinian Arab families with hearing loss that varies in mode of inheritance and severity. Results: A custom 1.46 MB design of c RNA oligonucleotides was constructed containing 246 genes responsible for either human or mouse deafness. Paired-end libraries were prepared from 11 probands and bar-coded multiplexed samples were sequenced to high depth of coverage. Rare single base pair and indel variants were identified by filtering sequence reads against polymorphisms in db SNP132 and the 1000 Genomes Project. We identified deleterious mutations in CDH23, MYO15A, TECTA, TMC1, and WFS1. Critical mutations of the probands co- segregated with hearing loss. Screening of additional families in a relevant population was performed. TMC1 p. S647P proved to be a founder allele, contributing to 34% of genetic hearing loss in the Moroccan Jewish population. Conclusions: Critical mutations were identified in 6 of the 11 original probands and their families, leading to the identification of causative alleles in 20 additional probands and their families. The integration of genomic analysis into early clinical diagnosis of hearing loss will enable prediction of related phenotypes and enhance rehabilitation. Characterization of the proteins encoded by these genes will enable an understanding of the biological mechanisms involved in hearing loss.
机译:背景:鉴定具有医学重要性状的基因是人类遗传学的主要挑战。由于听力损失的遗传异质性,靶向DNA捕获和大规模并行测序是应对这一挑战的理想工具。我们进行基因组分析的对象是听力损失因遗传方式和严重程度而异的以色列犹太人和巴勒斯坦阿拉伯家庭。结果:构建了定制的1.46 MB c RNA寡核苷酸设计,其中包含246个与人类或小鼠失聪有关的基因。从11个先证者制备了配对末端文库,并对条形码多路复用的样本进行了测序,以达到较高的覆盖深度。通过过滤针对db SNP132和1000 Genomes Project中多态性的序列读数,鉴定了罕见的单碱基对和indel变异。我们鉴定出CDH23,MYO15A,TECTA,TMC1和WFS1中的有害突变。先证者的重要突变与听力损失共同存在。对相关人群中的其他家庭进行了筛查。 TMC1页S647P被证明是奠基者等位基因,占摩洛哥犹太人口遗传性听力损失的34%。结论:在11个原始先证者及其家人中,有6个被鉴定为关键突变,从而在另外20个先证者及其家人中鉴定了致病性等位基因。将基因组分析整合到听力损失的早期临床诊断中,将能够预测相关的表型并增强康复能力。这些基因编码的蛋白质的表征将使人们了解与听力损失有关的生物学机制。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号